Results 271 to 272 of about 30,146 (272)
Some of the next articles are maybe not open access.

Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis

Leukemia, 2016
exaly  

Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib

Frontiers in Oncology, 2019
Elena Rossi   +2 more
exaly  
myelofibrosis
diseases of the blood and blood-forming organs
jak inhibitor
atopic dermatitis
pyrazoles
myeloproliferative neoplasms
primary myelofibrosis
ruxolitinib cream
pyrimidines
previous   26  27  28  

Home - About - Disclaimer - Privacy